August 2017

July 2016

AB Science: Development of masitinib, a novel tyrosine kinase inhibitor and immunotherapeutic, for the treatment of peripheral T-cell lymphoma

By |2017-08-21T10:01:53+00:00July 18th, 2016|Latest Articles|

Nulla sit amet nunc massa. Praesent sed est pellentesque, varius tellus non, efficitur nisi. Sed sit amet purus in odio varius tincidunt. Mauris ut ante lobortis, elementum orci efficitur, bibendum leo.